Farmacovigilância no tratamento com peginterferon e ribavirina em pacientes com hepatite C crônica no serviço de hepatologia do Hospital Universitário de Aracaju-SE
Hepatitis C is an infectious disease with an overall prevalence of 2.2% and Brazil 1.5%. Drug therapy consists of interferon α, peginterferon α and ribavirin. It is filled with aggressive treatment of adverse reactions, hence the importance of pharmacovigilance as an additional tool in monitoring th...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | Portuguese |
| Published: |
Universidade Federal de Sergipe
2017
|
| Subjects: | |
| Online Access: | https://ri.ufs.br/handle/riufs/3715 |